
By Collin West
At my prior fund, we invested in the Series B of Sidecar Health with Alex Lazarow at Cathay Innovation. Now, only six months later, they announced a $125 million raise at a $1 billion valuation. Our original investment thesis can be found here: How to Save $1 Trillion in Healthcare.
Since the fundraise, the Sidecar Health team has been busy turning their vision into a reality. We sat down with Patrick Quigley, Sidecar Health CEO, to get an update on the recently-minted unicorn.
A Change in Philosophy
Their team is motivated by a singular mission: to make healthcare affordable and accessible for everyone in the United States. This one idea drives all their major decisions.
“We are creating a new way to purchase healthcare. We give people the information they need to make purchasing decisions, like they have access to in every other market,” stated Patrick. “This is not some niche product. This is an entirely new philosophical approach to the U.S. healthcare system.”
Another Sidecar Health investor Alex Lazarow, Partner at Cathay Innovation, agrees: “Sidecar Health is not about incremental improvement to the health insurance market. It is about fundamentally rethinking how it is structured, shifting the underlying incentives and how healthcare is paid for. They are a strong example of an emerging cadre of startups that combine business model and technological shifts to drive greater access and better delivery of high impact products and services."
When we first spoke to Sidecar Health, they had internal benchmarks that they wanted to hit. They were eager to get the results and see if consumers would save money compared to the way that care and payments are handled today.
“After looking at the claims data from thousands of users, we see that price transparency reduces the cost of care. In many cases, the savings exceed 30%,” shared Patrick. This savings allows Sidecar Health to offer better coverage for a lower price, which is great for patients. This also makes it difficult for other insurers to compete on price.
These findings are particularly exciting because they confirm the research from Vanderbilt professor and economist Larry Van Horn, who is an advisor to the company.
How are Healthcare Providers Responding?
The Sidecar product offering is clearly working for consumers – but what about healthcare providers? Since introducing their upfront cash model, most healthcare providers have been enthusiastic supporters.
“Providers want to get paid quickly and the providers themselves set the cash price, not Sidecar Health. This is an important distinction,” said Patrick. “Providers can set prices wherever they want, and decide how they want to balance business levels and profitability. Their patients – now consumers – can shop with total confidence knowing exactly what services and procedures will cost.”
Unlike reference-based pricing models, Sidecar Health pays immediately when members use their payment card. Sidecar Health members can choose any provider, and are responsible for the shortfall (if any) between the benefit amount and the provider charge. In cases when the benefit amount exceeds the provider’s price, which happens frequently, Sidecar Health members keep the difference.
Their approach has been incredibly successful. In January 2021, Sidecar Health announced they recently joined the Unicorn Club due to the success of their product offerings. This capital will be used to fuel their expansion into new markets. “Our early membership has proven this model. Now we are taking the company to the next level. This round of financing is really about scaling our mission to make healthcare more affordable for everyone.”
Welcome to the team, Hannah Vu!
We’re excited to welcome Hannah Vu to Ensemble VC as a Data Engineer, where she’ll help scale the back-end infrastructure that powers Unity, Ensemble's proprietary data platform.
Rare Earth Elements: The Next Big Thing Is Buried
In a world obsessed with software, the next decacorn might come from a mine. With China controlling 90% of rare earth processing, a new industrial frontier is opening for founders to rebuild the backbone of modern technology—starting with the ground beneath our feet.
Welcome to the team, Aidan Gold!
Ensemble is thrilled to add Aidan Gold to the team. Aidan leads the investment pipeline at the earliest stages of company development.
CHAOS Industries reaches $2B valuation in Series C led by Accel, NEA
CHAOS Industries, a next-generation DefenseTech startup backed by Ensemble at Series B, has raised $275M in a Series C led by Accel and NEA at a $2B valuation, cementing its status as one of Fund II’s breakout successes and validating Ensemble’s data-driven approach to early access in frontier sectors.
Khosla Ventures doubles down on Loti AI, leads $16.2M Series A round
We’re thrilled to share that Loti has announced its $16.2M Series A, led by Khosla Ventures with participation from Ensemble VC, Bling Capital, and FUSE.
Why Ensemble is backing Manifest on its mission to bring transparency to software supply chains in the AI era
Ensemble VC leads the Series A for Manifest, a cybersecurity startup founded by Palantir veterans to build the leading software transparency platform. Manifest creates SBOMs to expose hidden vulnerabilities in critical infrastructure, helping major organizations like the U.S. Air Force and Fortune 500 companies secure their software supply chains. Learn how Manifest is shaping the future of AI-driven software security.